(Q77131915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Steroids in muscular dystrophy: where do we stand? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

A L Dubrovsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D M Bonifati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

E Pegoraro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

L Mesa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

published in

Neuromuscular Disorders

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

380-384

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

Prednisone in Duchenne muscular dystrophy

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Prednisone in Duchenne dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Steroids in duchenne muscular dystrophy — Deflazacort trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Deflazacort in Duchenne dystrophy: study of long-term effect

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

A synergistic effect of glucocorticoids and insulin on the differentiation of myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Methylprednisolone selectively affects dystrophin expression in human muscle cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal muscle satellite cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Prolongation of walking in Duchenne muscular dystrophy with lightweight orthoses: review of 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

A randomized controlled trial of early surgery in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900047-9

7 January 2021

10.1016/S0960-8966(98)00047-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9713854%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference